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Abstract 
Asthma is one of the most prevalent chronic health conditions among children and adults. Due to increasing 
incidence and prevalence of Tamaka Shwasa (bronchial asthma) there is a need of prevention. In Ayurveda for 
management of Tamaka Shwasa medicines are available and for prevention some methods are available like 
Dhumapana, Vaman, Swedan, Virechan, Nasya (Pratimarshya Nasya) Karma. It may help to relive the complaints, 
and prevents further attack. So there is a need to find a suitable measure for this purpose. So effect of Pratimarsha 
Nasya and Dhumapana in prevention of Tamaka Shwasa (Seasonal Bronchial Asthma) is assessed in this study. 
Materials & Methods: An open Randomised clinical trial was carried out on 30 patients who were equally divided 
into two groups, between the ages of 18-60 years. The duration of treatment was 2 months. Clinical evaluation was 
done by assessment criteria, subjective and objective parameter. Results:  Pratimarsha Nasya and Dhumapana are 
effective in decreased AEC and increased FVC, FEV1 in studied cases and showed significant results regarding 
subjective parameters in both groups.Discussion & Conclusion:  It can be concluded that Pratimarsha nasya and 
Dhumapana can be used as effective and safe therapeutic procedure in the prevention of Tamaka Shwasa (Seasonal 
Bronchial Asthma). 
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Introduction 
Ayurveda is the most ancient science of life. It is 
not only the science of life but also the philosophy of 
life. The first intend of Ayurveda is to maintain the 
healthy status of the people with the prevention of 
unborn diseases and second one is to treat the already 
arisen diseases(1). Ayurveda postulates the unique 
principles of Tridosha, Dhatu and Mala for 
homeostasis of the body. The living body can function 
normally, only when its doshas, dhatus, and malas are 
in a state of equilibrium Among all the systems in the 
human body, respiratory system is very important as 
the breathing strengthens or supports life physically or 
mentally. It helps in clearing the mind and calms the 
emotions by releasing the brisk flow of energy within 
us. 
 Respiratory system is the one which is more 
vulnerable to diseases, as it is in direct contact with 
external environment. Many of the inhaled substances 
produce a pathological stipulation of pranavahasrotas 
leading to the manifestation of the disease named as 
Shwasa. Tamaka shwasa is mentioned as one of the 
variety among panchavidha shwasa.Tamaka Shwasa is a 
svatantra vyadhi and having its own etiology, pathology 
and management. It is mentioned as chronic in nature 
and compared to bronchial asthma. 
Vata and kapha are the two key pathological 
factors involved in the samprapti of tamakashwasa. The 
predominant morbidity of vata and kapha dosha, which 
stems out from the pittasthana, afflicts the rasa dhatu 
disturbing the function of pranavahasrotas. Then, it 
leads to the manifestation of tamaka shwasa(2). 
 
Prevalence of Asthma 
The Global Strategy for Asthma Management and 
Prevention Guidelines define Asthma as a chronic 
inflammatory disorder of the airways associated with 
increased airway hyper-responsiveness, recurrent 
episodes of wheezing, breathlessness, chest tightness, 
and coughing, particularly at night/early morning. 
Airway inflammation produces airflow limitation 
through acute broncho constriction, chronic mucus plug 
formation and airway wall swelling or remodelling(3). 
Asthma is one of the most prevalent chronic health 
conditions among children and adults. A genetic 
predisposition to asthma is recognized to be more 
common in the so called developed countries as 
compared to developing countries. It has been reported 
that 2-7% of Indians have asthma prevalence for 
hospitalizations and while considering Global scenario, 
fatal asthma has increased in the United States over the 
past 20 years. Each year approximately 470,000 hospital 
Published online in http://ijam. co. in 
175 
International Journal of Ayurvedic Medicine, 2017, 8(4), 174-181 
ISSN: 0976-5921 
admissions and 5000 deaths in the United States are 
attributed to asthma. As stated by WHO 100–150 
million of global populations are suffering from 
Bronchial Asthma, out of which 1/10th are Indians and 
the prevalence of Asthma is increasing everywhere. 
Current estimates suggest that 300 million people 
worldwide suffer from Asthma and an additional 100 
million may be diagnosed with Asthma by 2025. 
According to the WHO by the year 2020 Asthma along 
with Chronic Obstructive Pulmonary Disease will 
become the third leading cause of death(4). 
 Mortality due to asthma is not comparable in 
size to the day-to-day effects of the disease. The social 
and economic burden associated to asthma is severe(5). 
In order to decrease these burdens, Tamaka shwasa 
demands distinct remedy. Thus, more and more 
research work is the need of the day either in bringing 
about a cure for this illness or else effective control.  
The emergence of this disease as a public health 
problem indicates the need of prevention. In modern 
medical science various medicines are available for 
management but results are unsatisfactory and they 
have many adverse effect. So the prevention is the only 
alternative. In Ayurveda for management of Tamaka 
Shwasa medicines are available and for prevention 
some methods are available like Dhumapana, Vaman, 
Swedan, Virechan, Nasya (Pratimarshya Nasya) Karma
(6). It may help to relive the complaints. So there is a 
need to find a suitable measure for this purpose. So 
effect of Pratimarsha Nasya and Dhumapana in 
prevention of Tamaka Shwasa (Seasonal Bronchial 
Asthma) is assessed in this study.  
The sequential administration of snehana, 
svedana, shodhana, shaman, brimhana and rasayan 
line of treatment in a chronological order is explained in 
Charaka samhita(7). Among these different therapeutic 
procedures, shaman line of treatment plays an important 
role and   it is easy and also effective. Plenty of research 
works have been carried out in relation to the shamana 
line of treatment in Ayurveda, To achieve samyata of 
vitiated dosha, is the main aim of treatment .To achieve 
this, shodhana and shamana therapies are described. But 
Shodhan cannot be applied in every individual. Hence, 
an attempt is made to know about the therapeutic effect 
of Pratimarsha Nasya and Dhumapana as a preventive 
procedure in Tamaka shwasa. 
Two procedures taken for study were 
pratimarsha nasya and dhumapana. Pratimarsha nasya 
is given by anu tail and dhumpana is given by 
Devdarvadi dhumavarti. Tamak shwasa is a Vata 
Kaphaja disorder, so the drugs were selected which are 
Vata Kapha shamak and Ushna. 
Anu tail contains jeevanti, Devdaru, musta, 
daruharidra, tej patra, twak, ela, kantakari, nirgundi, 
bala, rasna etc.Almost drugs of anu tail are katu, laghu, 
snigdha, madhura, ushna in nature. Due to katu and 
ushna guna, it pacifies kapha and due to its snigdha 
and madhura guna, it pacifies vata. And some drugs 
Due to tikta, madhura rasa, sheeta veerya and madhura 
vipaka it pacifies pittta .Hence anu tail shows 
tridoshahara property, but it is mainly affect on vata 
and kapha dosha. 
So almost ingredients of anu tail are vata 
kapha shamak , Vatanuloman  and ushna in nature. 
Acharya charaka   says that those medicines which are 
vata kapha shamak , vata anulomana and ushna are 
effective in shwasa. So these medicines by clearing the 
airways give relief in shwasa. Hence pratimarshya 
nasya of anu tail is effective in shwasa. 
The other drug devdarvadi dhumavarti 
contains devdaru,bala, and jatamansi. Devdaru is tikta, 
snigdha, katu, It resolves inflammation, so it resolves 
bronchial inflammation in asthma. It is vata kapha 
shamak and expectorant. It is good anti allergic hence 
it is effective in asthma. Bala has snigdha, 
madhura,sheet property and vata pitta shamak. 
Jatamansi is tikta madhura rasa, sheet virya  katu 
vipaka, vata pitta shamak and tridoshhara.So all these 
drugs are effective in tamaka shwasa.These drugs 
when administered by dhumapana gives local effect to 
the bronchial wall relieving asthma more effectively. 
 
Materials and Methods 
Aims and Obejectives  
 To evaluate the effect of Pratimarsha Nasya in 
prevention of Tamaka Shwasa. 
 To evaluate the effect of Dhumapana in prevention 
of Tamaka Shwasa. 
 To evaluate the comparative effect of Pratimarsha 
nasya and Dhumapana in prevention of Tamaka 
Shwasa. 
 
Study design and duration 
The study design was open clinical trial of over 
30 cases of Tamaka Shwasa (Seasonal bronchial 
asthma).The patients were selected by random 
sampling method. The duration of treatment was 2 
months. Patients were equally divided into two groups, 
each group contains 15 patients. Pratimarsha Nasya is 
given in group A and Dhumapana is given in group B. 
 
Selection of cases- 
Patient suffering from Tamaka Shwasa 
(Seasonal Bronchial Asthma) fulfilling the inclusion 
and diagnostic criteria were selected from O.P.D. & 
I.P.D of swasthavritta & yoga and kaya Chikitisa 
department, National institute of Ayurveda (NIA) 
Hospital, Jaipur, Rajasthan, 30 cases were selected for 
the present study. 
 
Inclusion criteria 
1. Age between 18 to 60 years  
2. Irrespective of gender, religion and occupation. 
3. Samples showing the classical sign and symptoms 
of Tamaka Shwasa (Seasonal Bronchial Asthma 
 
Exclusion criteria 
1. Other complicated respiratory disease. 
2. Cardiac Complaints. 
3. Tamaka Shwasa with other Systemic disorders. 
4. Endocrine disorders like diabetes, Thyroid 
dysfunction etc. 
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Assessment criteria:  
Assessment of severity & improvement of 
subjective parameters (breathlessness, cough, coryza, 
wheezing, chest tightness, dryness of mouth, sweating on 
forehead) & objective parameters (ESR, AEC, FVC, 
FEV1, FEV1/FVC, PEFR,) were assessed. 
 
Subjective Criteria  
1. Dyspnoea (Shwasakrichatta) 
 
 
2. Cough (kasa) 
 
 
3. Wheezing (Ghurghurrak) 
 
 
4. Coryza (Peenas) 
 
 
5. Chest tightness (Parsva avgrihyate) 
 
 
  B.T. A.T. 
Absence of Dyspnea 0   0 
Occasionally < 2 Times /
week 
1   1 
Very often  > 2 Times/week 2   2 
Always throughout a week 3   3 
  B.T. A.T. 
No Cough   0   0 
Cough with no expectoration   1   1 
Cough with easy expectoration   2   2 
Cough with difficult 
expectoration 
  3   3 
  B.T. A.T
. 
No wheeze   0  0 
Unilateral wheeze audible on 
auscultation 
  1  1 
Bilateral wheeze audible on 
auscultation 
  2  2 
Unilateral or bilateral wheeze 
audible without auscultation 
  3  3 
  B.T. A.T. 
No Coryza   0   0 
Occasionally   1   1 
Very often   2   2 
Always ( Daily)   3   3 
  B.T. A.T. 
No   0   0 
Occasionally   1   1 
Very Often   2   2 
Always   3   3 
6. Profuse sweating on fore head (Lalaten 
Svidyata)  
 
 
7.  Dryness of mouth (Vishuskaasyam) 
 
 
Objective criteria: 
These are based on Laboratory investigations. 
 A)   Blood Examination - Before & after clinical 
trial.               
       1. ESR (Erythrocyte Sedimentation Rate) 
       2. AEC (Absolute Eosinophil Count) 
 
B)  Spirometry - Before & After clinical trial. 
     1. FVC% (Forced vital capacity) 
     2. FEV1% (Forced expiratory volume) 
     3. FEV1/FVC ratio 
     4. PEFR % (Peak expiratory flow rate)    
. 
Trial drug: 
Group A.  Pratimarsha  Nasya  -  By Anu Taila 
Anu Tail was prepared in the Pharmacy of National 
Institute of Ayurveda Jaipur. Tail was prepared 
according to method mentioned in Ashtanga Hridya 
by Acharya Vagbhatta.(8)     
Dose : Two drops  in each nostr il, twice a day 
(morning and evening) 
Duration : Two months 
Route of Administration: Nasal route. 
 
Procedure:   
            Patients were examined and explained about 
the Nasya briefly and the time chosen was morning 
and in the evening(8). 
 
Nasya   Karma: 
Pradhana Karma: 
 Patient made to lie down in supine position. 
 The head of the patient is lowered 
( Pravilambita).  
 Patient is asked to close his eyes. 
 The tip of patient’s nose was drawn upward by 
the left thumb. 
 At the same time with the right hand instilled 
2 drop of Anu Tail in both nostril, alternately 
and asked the patient to inhale deeply.   
 
  B.T. A.T. 
No   0   0 
Occasionally   1   1 
Very often   2   2 
Always   3   3 
  B.T. A.T. 
No   0   0 
Occasionally   1   1 
Very Often   2   2 
Always   3   3 
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Paschatkarma :  
 Patient in lying position is asked to count up to 
100 matra i.e. approximately 2 minutes. 
 The patient was asked to expel out the drug which 
comes in oropharynx. 
 
Group B.   Dhumapana  -  By Devdarvadi Dhumavarti 
Preparation of Dhumavarti: 
 Dhumavarti was prepared in the pharmacy of National 
Institute Ayurveda Jaipur. Dhumavarti was prepared 
according to method mentioned in Shwasa chikitisa in 
Bhavaprakash  Samhita by Acharya Bhavaprakash(9). 
        Dose: Three puffs each in each nostr il, three 
times continuously, twice a day (morning and evening 
after meal)(10). 
        Duration: Two months 
        Route and form of Administration: Nasal. 
Inhalation of the medicated smoke                     through 
nose and exhalation through mouth.(10) 
 
Method of Dhumapana: 
 To begin with the patient is thoroughly examined 
to confirm the indications as well as to rule out 
any of the contraindications.  
 Then the patient is made to sit in a knee high 
chair with his body erect and looking forwards.  
 He was asked to concentrate on the therapy and 
should not get distracted by external factors- like 
Sexual desire (Kama), Anger (Krodha), Fear 
(Bhaya) etc.  
 Both the eyes should be closed during the 
procedure. 
 For dhumpana chillum or pipe was used. It is 
straight conical pipe with end to end channel, 
made up of clay. While smoking, chillum should 
be placed in left hand .Chillum should be adjusted 
between index finger and middle finger. 
Traditionally wrap a piece of cloth at the mouth 
of the chillum which acts as a filter. 
 The Dhumavarti should be soaked in ghee for a 
day or night. 
  Then it should be inserted into the chillum 
( pipe) 
 Lit with the fire and smoke is inhaled 
 The right side of the nostril is closed by pressing 
with the right index finger 
 Then the patient is asked to inhale the Dhuma 
through the left nostril.  
 And then the patient is allowed to exhale the 
Dhuma only through the mouth. 
 This is repeated for three times by one nostril. 
 The same procedure should be applied to the 
opposite nostril by closing the left nostril with the 
left index finger and the smoke should be inhaled 
and expelled through the mouth. 
 The procedure should be repeated for three times. 
 During the procedure if the sputum comes out, 
the patient is asked to spit it out. 
 After Dhumapana, the patient should be advised 
to take rest for several minutes and then allowed 
to do his routines. 
 Pathya apathya was advised to the patient. 
 
Follow up study 
Patients were asked to attend the O.P.D in every 15 
days for the follow up study. 
 
Statistical analysis 
 The information gathered on the basis of 
observation made about various parameters  was  
subjected  to  statistical  analysis  in  terms  of  
Mean,  Standard Deviation and Standard error 
(SE). All the results calculated by using 
software:  GraphPad InStat 3.  
 For nonparametric data Wilcoxon matched-pairs 
signed ranks test is used, while for  parametr ic 
data Paired‘t’ Test is used and results 
calculated in each group. 
 
Observation and Results 
Table No. 1 : Demographic profile 
 
S. No. Findings Predominance Percent 
1. Age 16-30 (young adults) 43.33% (13) 
2. Sex Male 63.33% (19) 
3. Religion Hindu 93.33% (28) 
4. Habitat Urban 76.66% (23) 
5. Socio-economic status Upper middle class 56.66% (17) 
6. Occupation Service 40% (12) 
7. Family History Absent 83.33% (25) 
8. Addiction Tea/coffee 46.66% (14) 
9. Chronicity of disease 1-3 Year 56.66% (17) 
10. Aharaja Nidana Vishmashana 73.33% (22) 
11. Viharaja Nidana Dhuma 76.66% (23) 
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Table No. 2: Showing effect of therapy in all subjective parameters in group A.  
(Wilcoxon matched paired single ranked test) 
 
 
Table No. 3: Showing effect of therapy in all subjective parameters in group B.  
(Wilcoxon matched paired single ranked test) 
 
 
Table No.4: Showing effect of therapy on Objective Parameters in Group A (Paired‘t’ Test)
 
 
 
Variable 
     Mean Mean
Diff. 
% 
Relief 
SD± SE±      P S 
BT AT 
Shwasakrichatta   
(Dyspnoea) 
1.53 0.73 0.80 52.28
% 
0.676 0.174 P<0.001 H.S. 
Kasa 
(Cough) 
1.13 0.40 0.73 64.60
% 
0.593 0.153 P<0.001 H.S. 
Ghurghurrak 
(Wheezing) 
1.00 0.53 0.46 46% 0.516 0.133 P<0.01 S. 
Peenas  
(Coryza) 
0.60 0.20 0.40 66.66
% 
0.507 0.130 P<0.01 S. 
Parsva    avgrihyate  
(Chest tightness) 
 1.00  0.53   0.46 46 0.516 0.133 P <0.01 S. 
Lalaten svidyata 
(Sweating on forehead) 
 1.06  0.46  0.60 56.60
% 
0.828 0.213 P <0.01 S. 
Vishuskaasyam 
(Dryness of mouth) 
 1.33  0.86  0.46 34.58  0.743 0.191 P< 0.1 N.S. 
Variable      Mean MeanD
iff. 
% 
Relief 
SD± SE±      P S 
BT AT 
Shwasakrichatta  
(Dyspnoea) 
 1.46 0.93 0.53 36.30  0.639  0.165 P <0.01 S. 
Kasa 
(Cough) 
 1.60 0.73 0.86 53.75 0.743 0.191 P <0.001 H.S. 
Ghurghurrak 
(Wheezing) 
 1.06 0.66 0.40 37.73 0.507 0.130 P < 0.01 S. 
Peenas  
(Coryza) 
 0.80 0.20 0.60 75 0.828 0.213 P <0.01 S. 
Parsva    avgrihyate 
(Chest tightness) 
 0.73 0.33 0.40 54.79 0.507 0.130 P <0.01 S. 
Lalaten svidyata 
(Sweating on forehead) 
 0.93 0.46 0.46 49.46% 0.639 0.165 P<0.01 S. 
Vishuskaasyam 
(Dryness of mouth) 
 0.93 0.66 0.26 27.95 0.457 0.118 P< 0.1 N.S. 
Parameters 
Mean 
Diff 
% 
Relief 
SD± SE± T P S 
BT AT 
ESR 
  19.46   18.93    0.53   2.73% 1.457 0.376  1.41 P> 0.01   N.S. 
AEC 264.47 246.67   17.8  6.73% 29.20  7.541  2.36 P <0.01 S. 
FVC 65.20 67.53  -2.33  3.57% 3.132 0.808 2.88 P<0.01    S. 
FEV1  57.86  59.60  -1.74  3.00% 2.520 0.650  2.66 P< 0.01    S. 
FEV1/FVC 93.60 95.93 -2.33   2.48% 5.627  1.453  1.60 P< 0.1   N.S. 
PEFR 51.66 52.86 -1.2 2.32% 3.668 0.947 1.26 P<0.1   N.S. 
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Table No.5: Showing effect of therapy on Objective Parameters in Group B. (Paired‘t’ Test) 
 
N = 30 patients; BT - Before treatment; AT- After treatment; SD - Standard deviation; SE - Standard error  
P - P value; S - Significant; NS - Non significant; HS – Highly significant. 
 
Parameters 
Mean 
Diff % Relief SD± SE± T P S 
BT AT 
ESR 
  
  
  16.66   16.26    0.40   2.40 1.298 0.335  1.19 P> 0.01 N.S. 
AEC    255.40 242.00   13.4  5.24 19.99  5.162  2.59 P <0.01 S. 
FVC   
  
60.00 61.20 -1.20    2 1.897 0.489 2.44 P< 0.01 S. 
FEV1 
  63.40  64.86  -1.46   2.30 2.475 0.638 2.29 P< 0.01 S. 
FEV1/FVC   
  
98.93 100.80 - 1.87   1.89 4.086 1.055   1.76 <0.1 N.S. 
PEFR   57.33 58.46 -1.13 1.97 2.850 0.735 1.54 <0.1   N.S. 
Discussion on Results 
Group–A (Pratimarsha Nasya) 
The effect of Pratimarshya Nasya Group on 
symptomatology provided highly significant (p<0.001) 
with Moderate Relief with 52.28% in Shwasakrichatta 
and with 64.60% in Kasa,  
Statisticallysignificant(P<0.01) with Moderate 
relief with 66.66% in Peenas and with 56.60% in Lalten 
svidyata Mild Relief with 46% in Ghurghurrak and  
with 46% in Parsva avgrihyate. 
Statisticallynonsignificant (p<0.1)with  mild 
relief in 34.58% in V ishuskaasyam. 
  
Group – B (Dhumapana) 
The effect of Dhumapana Group on 
symptomatology provided highly significant (p<0.001) 
with Moderate Relief with 53.75% in Kasa. 
 Statistically significant (P<0.01) with Moderate 
relief 75% in peenas, 54.79% in Parsva avgrihyate and 
mild relief with 36.30% in Shwasakrichatta, 37.73% in 
Ghurghurrak,and with 49.46% in Lalaten svidyata. 
Statisticallynon-significant (p<0.1) with Mild 
Relief with 27.95% in Vishuskaasyam. 
Thus we may conclude that Pratimarsha Nasya of 
Anu tail is more effective on Vata and Kafa Dosha 
which provide better result in all signs and symptoms as 
compare to Dhumapana, whereas it was observed that 
Dhumapana is more effective in Peenas and Parsva 
avgrihyate as compare to Pratimarsha Nasya. 
 
Effect of Trial on Objective Parameter  
On the basis of both groups 
Effect on ESR 
 ESR was decreased by 2.73% in Group A and 
2.40% in Group B, which was Non significant (p<0.1) 
in both groups. 
 
Effect on AEC 
 AEC was decreased by 6.73% in Group A and 
5.24% in Group B, which was  statisticallysignificant 
(p<0.01) in both groups. 
 
Effect on Spirometry 
FVC% 
 FVC was increased by 3.57% in Group A and 2% 
in Group B, which was  statistically  significant 
(p<0.01) in both groups. 
 
FEV1% 
 FEV1 was increased by 3% in Group A and 
2.30% in Group B, which was  statistically  significant 
(p<0.01) in both groups. 
 
FEV1/FVC Ratio 
 FEV1/FVC Ratio was increased by 2.48% in 
Group A and 1.89% in Group B, which was statistically 
Nonsignificant(P<0.1) in both groups. 
 
PEFR% 
 PEFR was increased by 2.32% in Group A and 
1.97% in Group B, which was  statistically Non 
significant(P<0.1) in both groups. 
 
Discussion on Subjective Parameters 
Effect on Shwasakrichatta 
 The result was found statistically highly 
significant in group A, and Significant in group B. 
When the pranavahasrotas is obstructed by the kapha it 
causes  dysfunction of pranavayu leading to discomfort 
in breathing, kapha-vattaghana property  of Nasya (Anu 
taila) reduces the elevated kapha and its lekhana 
property cleans the srotas allowing the path for the 
movement of vayu. Same as Dhumapana (devdaru, 
bala, jatamansi) has kapha-vataghna property and with 
its  katu vipaka ushna veerya & tikshna guna, it reduces 
the symptom by doing srotoshodhana(11). 
 
Effect on Kasa 
 The result was found statistically highly 
significant in the both group, Cough is a defense 
mechanism of pranavahasrotas, the presence of which is 
indicative of irritating sleshma in the srotas. The 
reduction in the cough implies its tenacious sputum is 
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liquefied by the medicine (nasya and dhumapana) and 
its expectoration is easy. The medication is also 
effective when it reduces production of sputum in the 
srotas. 
  
Effect on ghurghurrak sound 
 The result was found statistically significant in 
both group. Increased Kapha situated in Srotas (Kantha) 
obstructs the airway causes wheezing sound. Most of 
the ingredients of both group possesses Kapha Shamaka 
and Shothahara properties with Lekhana Guna. Hence 
they are helpful in this symptom and When Dhumapana 
was taken stimulating expectoration, so its clear the 
airways and decrease wheezing(11). 
 
Effect on Peenas 
 Peenas is a kapha vata predominance disease 
and most of the ingredients of nasya having 
kaphavataaghna property as its local effect of 
elimination of vitiated doshas from nasa marga and 
gives relief from peenas. Majority of ingredients of 
Anutaila show Tikta Rasa and Laghu guna, properties. 
These properties are very much in favour of clearing the 
Srotas.It dries up Kelda and purulent discharge. Katu 
vipaka, Ushna Virya  and Tikshna properties  of drugs 
of dhumapana exert srotoshodhan effect and produce 
Draveekarana(Vilayana) and Chedana of vitiated 
Kapha(11). 
 
Effect on parsva avgrihyate 
 The result was found statistically significant in 
the both groups. pain in the chest and flank is due to 
vitiated kapha.Due to obstruction of air by mucous 
congestion in alveoli, if it is not expelled in time it 
obstruct the path of air in alveoli which is responsible 
for the phenomena of chest tightness. Drugs of both 
groups has vataanuloman and kaphanisarak property, so 
above result is derived(11). 
 
Effect on Lalaten svidyata 
 The result was found statistically significant in 
both groups with mild relief.  This might be due to the 
reason that asthmatic attack causes rapid respiration and 
hence exertion which in turn is the reason for sweating, 
and when difficulty in breathing subsides this symptom 
of sweating gets subsided automatically. 
 
Effect on Vishuskaasyam 
 The result was found statistically insignificant in 
both groups. This might be due to the reason the 
property of the trial drug may be unable to pacify the 
symptom vishuskaasyam. 
 
Discussion of Objective Parameter 
Effect on ESR    
 There was no significant difference noticed in 
ESR during the course of   whole treatment. 
Effect on AEC 
There was significant result found on AEC in 
both group. High eosinophil value suggests allergic 
condition and extrinsic type of asthma,Due to 
antihistaminic properties of drug and improvement in 
the immune system with the both drug reduction in AEC 
value is observed. 
 
Effect on Spirometry 
Spirometry measures the amount (volume) and 
speed or flow of air that can be inhaled and exhaled. It 
helps in detecting the narrowing or obstruction of 
airways. The most common measurements used are 
FVC, FEV1, FEV1/FVC ratio and PEFR. Improvement 
in the value suggest improvement in airway obstruction 
in alveoli and inflamed airway and broncho constriction 
in asthma improved. Due to expectorant, antispasmodic, 
and anti-inflammatory property of drug this significant 
result was observed. 
 
Probable Action of Drug 
Pratimarsha Nasya with anu tail and dhumapana 
includes the drugs having Antinflammatory, 
Antihistaminic,Antiallergic, bronchodilator and 
expectorant properties,which are effective and safe 
therapeutic procedures in the prevention of Tamaka 
Shwasa ( Seasonal Bronchial Asthma). 
 
Conclusion  
Tamak Shwasa (Bronchial asthma) is most 
common health problem, occurs due to excessive 
pollution, overcrowding and industrialization as well as 
urbanization. It can be said that Pratimarshya nasya  is 
more effective to control all parameters due to its highly 
Vata-kaphahara and Vataanuloman properties compare 
to Dhumapana.Thus it can be concluded that 
Pratimarsha nasya and Dhumapana are effective in 
reducing the severity of attack and can be used as 
effective and safe therapeutic procedure in the 
prevention of Tamaka Shwasa ( Seasonal Bronchial 
Asthma). 
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